| Name |
Endoxan 200 mg prašak za otopinu za injekciju/infuziju |
| Marketing Authorisation Number |
HR-H-082504880 |
| Active Substance |
ciklofosfamid hidrat |
| Composition |
jedna bočica sadrži 200 mg ciklofosfamida u obliku ciklofosfamid hidrata |
| Pharmaceutical Form |
prašak za otopinu za injekciju/infuziju |
| Manufacturer |
Baxter Oncology GmbH, Halle (Westfalen), Njemačka |
| Marketing Authorisation Holder |
Baxter d.o.o., Letališka cesta 29A, Ljubljana, Slovenija |
| Marketing Authorisation Date |
26.04.2019 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/279 |
| Registration Number |
381-12-01/30-19-14 |
| Prescription |
na recept |
| Type of prescription |
ograničeni recept
|
| Distribution |
u ljekarni |
| Advertising to general public |
zabranjeno |
| ATC Code |
L01AA01 |
| Medicinal product marketed in the Croatia |
Da |
| SmPC |
download |
| PL |
download |
